PMID: 11337166May 5, 2001Paper

Effect of liposomes and niosomes on skin permeation of enoxacin

International Journal of Pharmaceutics
J Y FangY Y Wang

Abstract

The skin permeation and partitioning of a fluorinated quinolone antibacterial agent, enoxacin, in liposomes and niosomes, after topical application, were elucidated in the present study. In vitro percutaneous absorption experiments were performed on nude mouse skin with Franz diffusion cells. The influence of vesicles on the physicochemical property and stability of the formulations were measured. The enhanced delivery across the skin of liposome and niosome encapsulated enoxacin had been observed after selecting the appropriate formulations. The optimized formulations could also reserve a large amount of enoxacin in the skin. A significant relationship between skin permeation and the cumulative amount of enoxacin in the skin was observed. Both permeation enhancer effect and direct vesicle fusion with stratum corneum may contribute to the permeation of enoxacin across skin. Formulation with niosomes demonstrated a higher stability after 48 h incubation compared to liposomes. The inclusion of cholesterol improved the stability of enoxacin liposomes according to the results from encapsulation and turbidity. However, adding negative charges reduced the stability of niosomes. The ability of liposomes and niosomes to modulate drug d...Continue Reading

References

Jun 1, 1991·Chemical & Pharmaceutical Bulletin·H IshiharaK Hosoi
Jan 1, 1989·Clinical Pharmacokinetics·F SörgelU Stephan
Jan 1, 1989·Clinical Pharmacokinetics·S H Zinner
Nov 1, 1988·Chemical & Pharmaceutical Bulletin·C PiraubeD Pradeau
Nov 15, 1986·Analytical Biochemistry·E Goormaghtigh, G A Scarborough
Jul 1, 1995·Pharmaceutica acta Helvetiae·S Vemuri, C T Rhodes
Sep 1, 1994·Journal of Pharmaceutical Sciences·E TouitouM Mezei
Jun 1, 1993·Chemical & Pharmaceutical Bulletin·N HazemotoY Kato
Aug 1, 1996·The Journal of Pharmacy and Pharmacology·H H LinY H Tsai
Jan 1, 1996·Journal of Pharmaceutical Sciences·N B VutlaA K Banga
Jan 1, 1996·Journal of Pharmaceutical Sciences·T OgisoM Iwaki
Sep 2, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·B VoraN K Jain
Oct 10, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·J Y FangY H Tsai
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·C ValentaJ Heidlas

❮ Previous
Next ❯

Citations

Mar 17, 2004·Advanced Drug Delivery Reviews·Gregor Cevc
Apr 10, 2004·International Journal of Pharmaceutics·Ramesh R BoinpallyBhaskara R Jasti
Mar 22, 2005·International Journal of Pharmaceutics·Prem N GuptaSuresh P Vyas
May 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Isabella SchöllErika Jensen-Jarolim
Dec 14, 2002·International Journal of Pharmaceutics·M BudaiPál Gróf
Jul 15, 2005·Skin Pharmacology and Physiology·M J Choi, H I Maibach
Jul 19, 2008·AAPS PharmSciTech·Varaporn Buraphacheep JunyaprasertTasaneeya Supaperm
Jan 20, 2012·AAPS PharmSciTech·Aranya ManosroiJiradej Manosroi
Jun 3, 2005·Chemical & Pharmaceutical Bulletin·Mei-Ying NingZhong-Wei Gu
Oct 26, 2013·Nanomedicine·Orapan PaecharoenchaiRobert J Lee
Apr 12, 2014·Chemistry and Physics of Lipids·Seongyeol YeomSanghwa Han
Apr 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saeid Moghassemi, Afra Hadjizadeh
Aug 16, 2014·International Journal of Pharmaceutical Investigation·Mohd YusufKamla Pathak
Aug 2, 2011·Archives of Dermatological Research·Maria Bernadete Riemma Pierre, Irina Dos Santos Miranda Costa
Aug 1, 2011·Drug Delivery and Translational Research·Sanyog JainNitin K Swarnakar
Oct 31, 2014·Journal of Liposome Research·Nida AkhtarKamla Pathak
Jan 10, 2014·Drug Delivery·Saeed GhanbarzadehSanam Arami
Aug 31, 2012·Journal of Drug Targeting·Orapan PaecharoenchaiPraneet Opanasopit
Jul 2, 2008·Expert Opinion on Drug Delivery·D CoscoD Paolino
Aug 12, 2005·Drug Development and Industrial Pharmacy·Meiying NingZhongwei Gu
Jul 10, 2014·Drug Delivery·Harneet MarwahGoutam Rath
Mar 16, 2011·Journal of Pharmaceutical Sciences·Raju JukantiPrabhakar R Veerareddy
Dec 30, 2009·Journal of Pharmaceutical Sciences·Carmelo PugliaElisabetta Esposito
Oct 20, 2012·International Journal of Pharmaceutics·M GallarateM Trotta
Apr 12, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Aranya ManosroiJiradej Manosroi
Feb 14, 2012·Colloids and Surfaces. B, Biointerfaces·Thi Thuy PhamHatem Fessi
Apr 26, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Barbara GeusensJo Lambert
Nov 9, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hanan M El-LaithyLaila G Mahran
Dec 29, 2015·Pharmaceutical Development and Technology·Praneet OpanasopitBoon-Ek Yingyongnarongkul
Jul 6, 2010·International Journal of Pharmaceutics·Ghada M El ZaafaranyNahed D Mortada
Apr 6, 2005·The Journal of Pharmacy and Pharmacology·Prem N GuptaSuresh P Vyas
Oct 16, 2004·The Journal of Pharmacy and Pharmacology·Carmelo PugliaFrancesco Bonina
Aug 18, 2005·The Journal of Pharmacy and Pharmacology·Sanyog Jain, S P Vyas
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chiara SinicoAnna Maria Fadda
Oct 31, 2006·International Journal of Pharmaceutics·Markos Trikeriotis, Demetrios F Ghanotakis
May 30, 2006·Vaccine·Vivek MishraSuresh P Vyas

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.